Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.

Ennis MD, Hoffman RL, Ghazal NB, Olson RM, Knauer CS, Chio CL, Hyslop DK, Campbell JE, Fitzgerald LW, Nichols NF, Svensson KA, McCall RB, Haber CL, Kagey ML, Dinh DM.

Bioorg Med Chem Lett. 2003 Jul 21;13(14):2369-72.

PMID:
12824036
2.

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB.

J Pharmacol Exp Ther. 2002 Jun;301(3):1166-78.

PMID:
12023552
3.

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA.

Biol Psychiatry. 2000 May 1;47(9):818-29.

PMID:
10812041
4.

Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.

Piercey MF, Hyslop DK, Hoffmann WE.

Brain Res. 1997 Jul 11;762(1-2):19-28.

PMID:
9262154
5.

Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.

Heier RF, Dolak LA, Duncan JN, Hyslop DK, Lipton MF, Martin IJ, Mauragis MA, Piercey MF, Nichols NF, Schreur PJ, Smith MW, Moon MW.

J Med Chem. 1997 Feb 28;40(5):639-46.

PMID:
9057850
6.
7.

Excitation of type II caudate neurons by systemic administration of dopamine agonists.

Piercey MF, Hyslop DK, Hoffmann WE.

Brain Res. 1996 Jan 15;706(2):249-58.

PMID:
8822364
8.

Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.

Yocca FD, Eison AS, Hyslop DK, Ryan E, Taylor DP, Gianutsos G.

Life Sci. 1991;49(24):1777-85.

PMID:
1682780
9.
10.

Radioreceptor assay of dopamine binding activity in human serum after tiospirone administration.

Hyslop DK, Westrick ML, Shukla UA, Taylor DP.

Ther Drug Monit. 1989;11(3):295-303.

PMID:
2728088
11.

BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes.

Yocca FD, Hyslop DK, Smith DW, Maayani S.

Eur J Pharmacol. 1987 Jun 4;137(2-3):293-4. No abstract available.

PMID:
2886356
12.

Treatment with trazodone plus phenoxybenzamine accelerates development of decreased type 2 serotonin binding in rat cortex.

Taylor DP, Allen LE, Ashworth EM, Becker JA, Hyslop DK, Riblet LA.

Neuropharmacology. 1981 May;20(5):513-6. No abstract available.

PMID:
7242871
13.

Trazodone does not competitively inhibit binding at muscarinic cholinoceptors.

Taylor DP, Hyslop DK, Becker JA.

Gen Pharmacol. 1981;12(5):391-2. No abstract available.

PMID:
7286609
14.

Trazodone, a new nontricyclic antidepressant without anticholinergic activity.

Taylor DP, Hyslop DK, Riblet LA.

Biochem Pharmacol. 1980 Aug 1;29(15):2149-50. No abstract available.

PMID:
7406927
15.

The interaction of trazodone with rat brain muscarinic cholinoceptors.

Hyslop DK, Taylor DP.

Br J Pharmacol. 1980;71(2):359-61.

Supplemental Content

Loading ...
Support Center